Biotech Week articles from October 2001

Biotech Week archives from October 2001

Favorable Genetic Factors Same For Progression, Vaccine Efficacy.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Gene polymorphisms linked to favorable prognoses after HIV infection are also associated with positive responses to HIV vaccines, researchers say. ...

InterMune Carries Forward Work On MAb Compound.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- InterMune Inc. has agreed to develop a humanized monoclonal antibody targeted against the PcrV protein of the bacterium Pseudomonas aeruginosa. The monoclonal form of the antibody was developed by a...

Physiome Sciences Licenses Biological Modeling Technology.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- In an effort to advance Huntington Disease research, 3rd Millennium Inc. has licensed the PathwayPrism biological modeling technology from Physiome Sciences Inc. to use in conjunction with data...

Update Provided On Left Ventricular Assist System.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Arrow International, Inc. (ARRO) announced that during the month of August 2001 there were no additional implants of the Arrow LionHeart, a fully implantable left ventricular assist system (LVAS)....

Microparticle Adsorption Augments Efficacy.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - DNA-based HIV vaccines are more effective when delivered on the surface of charged particles, according to researchers in the United States. Derek...

Restenosis Blocked By Use Of Sirolimus-Eluting Stent.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Cordis reported results from a landmark European clinical trial suggesting the Cypher Sirolimus-eluting Stent dramatically reduces late loss and the incidence of restenosis (reblockage of arteries)...

Preclinical Studies Of CRL-5861 Are Encouraging.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- CytRx Corporation announced results from experimental studies investigating the combination effect of its development-stage drug, CRL-5861 (purified poloxamer 188) with the anticancer agent...

Positive Results From Chronogesic Long-Term Relief Trial.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- DURECT Corporation has announced the results of its Phase II clinical trial for its lead product Chronogesic, a three-month continuous infusion subcutaneous implant for the treatment of chronic...

Three-D Display System Analyzes Genetic Variation Data.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Variagenics Inc., unveiled a new interactive three-dimensional visualization system for individual genetic variations, at the recent 2001 Drug Discovery Technology Conference. The system...

FDA Places Clinical Hold On Vaccine Trials.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- AVAX Technologies Inc. (AVXT), has submitted its response to the Food and Drug Administration's (FDA) clinical holds of the company's M-Vax and O-Vax autologous cancer vaccine clinical trials....

Allos Names Regulatory Affairs And Clinical Development Executives.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics Inc. (ALTH) has named Markus F. Herzig Vice President of Regulatory Affairs. He will oversee Allos' national and international regulatory activities and will report to Michael J....

Second Quarter Losses Due To Stepped-up Spending on Ovarian Cancer Drug.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO), a developer of antigen-targeted antibody-based cancer therapeutics, reported a net loss of $7.5 million or $0.28 per share for the three months ended June 30, 2001 compared with...

Trial To Examine Ability Of Metoprolol Succinate To Reverse Cardiac Remodeling.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- AstraZeneca has announced the initiation of a clinical trial to examine the ability of the beta-blocker Toprol-XL (metoprolol succinate) extended-release tablets to reverse the cardiac remodeling...

IND Filed For IV Formulation Of Novel Anti-Inflammatory Drug.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc. has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for AGIX-4207 I.V., a novel, intravenously administered drug for the...

Gastric Bypass Strips Credited For Bio-Vascular Revenue Growth.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Bio-Vascular Inc. (BVAS) reported that its consolidated net revenue increased 12% to $7,087,000 in its third quarter ending July 31, 2001, from $6,354,000 in the same period of fiscal 2000, at least...

BresaGen Among Founders Of New Stem Cell Facility.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- BresaGen Inc., the U.S. operation of BresaGen Ltd. of Adelaide, Australia (BGN.AX), will participate in a collaborative research program that is aiming to develop a new research facility under a...

Sustained-Release Ranolazine Gets Patent Approval.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- CV Therapeutics Inc. (CVTX), has received a Notice of Allowance from the U.S. Patent and Trademark Office for a method of using ranolazine sustained release (SR) formulations, including the...

Transdermal Testosterone Gel Looks Like Promising Therapy.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc. (CLGY) announced that it has successfully completed a second Phase I/II clinical trial using Tostrelle, its transdermal testosterone gel product for the treatment of...

JBWere Invests $9.9 Million In Australian Biotech Firm.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- The JBWere Private Equity Fund has completed a $9.9 million investment in the Australian drug discovery company, Cerylid Biosciences Ltd. The equity investment is indicative of the strength of...

SynerGraft Ready For Marketing In Europe.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- CryoLife Inc. (CRY) has received a CE (product certification) Mark allowing the commercial distribution of its SynerGraft Model 100 tissue-engineered vascular graft within the European Community....

Enchira Attributes Second Quarter Losses To Arbitration Costs.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Enchira Biotechnology Corp., which develops anticancer therapies, announced that revenues for its second quarter were $273,965, compared with $70,468 for the same period in 2000. Enchira...

Independent Researchers Confirm Effect Of Pheromones On Brain.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- In response to inquiries received as a result of an article published in The Washington Post and other newspapers on August 28, 2001, Human Pheromone Sciences, Inc. (HPS) confirmed that the...

Genomics System Combats Deadly Bacterial Complications Of AIDS, Cystic Fibrosis.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Infectech Inc. (IFEC) has received a U.S. patent for its method for detecting and killing nontuberculous mycobacteria and Pseudomonas, both leading causes of death and suffering for 37 million...

Topical Estrogen Replacement Therapy Accepted For Review.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- King Pharmaceuticals, Inc. reported September 5, 2001, that the U.S. Food and Drug Administration has accepted for review the New Drug Application (NDA) for Estrasorb (17-beta-estradiol) cream, a...

Marketing Clearance For Advicor Tablets Expected By Year End.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has completed the satisfactory inspection of Kos Pharmaceuticals' primary manufacturing facility for Advicor (extended-release niacin/lovastatin)...

New Director Of Corporate Development Named.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Dr. Abderrahim Mahfoudi has joined Nautilus Biotech as Director of Corporate Development. Dr. Mahfoudi received his PhD in molecular and cellular biology with an emphasis in reproductive...

NeoTherapeutics Reports Second Quarter Results.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- NeoTherapeutics Inc. (NEOT, NEOTW), which develops drugs for neurodegenerative disorders, reported a net loss of $6.6 million, or $0.36 per share for the second quarter ended June 30, 2001, compared...

Lab Submits Biologics License Application For PolyHeme.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Northfield Laboratories, Inc. (NFLD) reported that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval to market its patented blood...

Quintiles, Novia Join To Develop Central Nervous System Compound.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Quintiles Transnational Corp. (QTRN) and Novia Pharmaceuticals Ltd. have formed an alliance to provide preclinical services for Novia's lead compound to treat central nervous system (CNS) disorders,...

FDA Accepts Proposed Response Plan Regarding Xyrem NDA.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Orphan Medical Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company's plan for a complete response to the agency's Approvable Letter dated July 2, 2001,...

Proteomics Of Aging Investigated In New Program.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Proteome Systems and the Buck Institute for Age Research are collaborating to investigate the proteomics of aging. A pilot program will focus on mitochondrial oxidative stress and the role of...

FDA Grants Fast Track Designation For Secretin Therapy.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Repligen Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for secretin for the treatment of pediatric autism. Under the FDA...

Immunotherapeutic Could Help High Grade Patients Avoid Surgery.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Stressgen presented positive data concerning their immunotherapeutic drug, HspE7, and the treatment of anal dysplasia. The data showed that up to 71% of high-grade anal dysplasia patients...

Generic HCV Drug In The Pipeline.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Three Rivers Pharmaceuticals, LLC, a Pittsburgh-based, privately owned company, has filed an Abbreviated New Drug Application with the U.S. Food & Drug Administration (FDA) for permission to market...

TKT Strengthens Technology Base With Patent For Protein Production, Delivery.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Transkaryotic Therapies Inc. (TKTX) has been issued a patent for its core technological base that is being used for a variety of purposes, including the production and delivery of protein...

Co-X-Gene Technology Will Target Advanced, Hormone-Refractory Disease.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- Virax Holdings Ltd. (VHL) has entered into a collaborative agreement with Dr. Michael Brown of Royal Adelaide Hospital's Cancer Centre to develop leads for an immune-based therapy to treat prostate...

Vitro Expands Cell Immortalization Program In Light Of Bush Announcement.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- President Bush's decision to allow limited federal funding for stem cell research provides additional opportunities for Vitro Diagnostics Inc. to expand its cell immortalization research program,...

NeoSan Acquires Nutrition Products From AstraZeneca.
October 3, 2001... 2001 OCT 3 - (NewsRx.com & NewsRx.net) -- aaiPharma Inc. (AAII) has acquired, through its business unit NeoSan Pharmaceuticals, a line of critical care injectable nutritional products from AstraZeneca AB, an affiliate of AstraZeneca PLC...

Filmless Cardiac Data Management System Cuts Error Potential.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Heartlab Inc. has introduced the Encompass i-Broker, a new component of the company's filmless cardiac data management system. The i-Broker is a message translator that can decode information from...

Interferon-Producing Cell Levels Linked To Progression Risk.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Patients infected with HIV are less likely to experience AIDS-defining events if they maintain relatively high levels of interferon-producing cells,...

Expanded Bone Marrow Can Improve Low-Dose Engraftment.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A system for the ex vivo expansion of bone marrow can be used to improve the likelihood of stem cell engraftment after transplantation, researchers in the...

Multinational Pivotal Trial For Inhaleable Therapy Initiated.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- This therapy utilizes the Inhance pulmonary delivery technology, a proprietary drug delivery solution from Inhale Therapeutic Systems, Inc., Aventis Behring's development partner. "We will be...

Can Genes Predict Effectiveness Of Hypertension Drugs?
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Whether subtle genetic variations among patients with hypertension can predict treatment effectiveness is the focus of a new research effort at the University of California, San Diego (UCSD) School...

Oligodeoxynucleotides Can Provoke Antileukemia Immune Response.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Certain pieces of DNA can be used to induce strong antileukemia immune responses in mice, researchers in the United States report. "Immunostimulatory...

Microvolume Laser Scanning Effective For Whole Blood Platelet Analysis.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States say that microvolume laser scanning cytometry (MLSC) is an effective technique for studying platelets in whole blood...

Integrated System For Producing Human Cells Gets Expanded Protection.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- A new U.S. patent has been issued to extend coverage for an integrated system of instrumentation and the related methods for receiving, maintaining, and growing human cells ex vivo within a...

Feridex I.V. Supplemental New Drug Application Not Approvable by FDA.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has determined that the supplemental New Drug Application (sNDA) submitted by Advanced Magnetics Inc. (AVM) for Feridex I.V. is not approvable. Feridex...

Biotechnology Value Fund Expands Investment in American Biogenetic Sciences.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- The Biotechnology Value Fund, L.P. (BVF) has invested an additional $2 million in American Biogenetic Sciences Inc. (ABS) (MABA), increasing BVF's total investment in ABS to $5 million. BVF...

Study Of Potential Cocaine Treatment Gets $1 Million NIH Grant.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- A grant from the U.S. National Institutes of Health (NIH) of more than $1 million will allow Applied Molecular Evolution Inc. (AME) to develop a potential treatment for acute cocaine toxicity and...

Intravascular Ultrasound System Introduced.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corp. (BSX) has launched the Galaxy System, its next-generation intravascular ultrasound (IVUS) imaging. It is now available in the United States and Canada and is scheduled for...

Bristol-Myers Squibb, ImClone To Co-Develop Cancer Therapies.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Drug maker Bristol-Myers Squibb Co. has agreed to co-develop and promote an experimental cancer drug being tested by ImClone Systems and to buy a sizable stake in the New York biotechnology...

Enrollment Completed For Phase III Testing Of INS365 Ophthalmic.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Inspire Pharmaceuticals, Inc. announced the completion of patient enrollment in two Phase III clinical studies for INS365 Ophthalmic eye drops for the treatment of dry eye. The...

Bristol-Myers Squibb Initiates Clinical Trials of Jointly Developed Obesity Drug.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Karo Bio and Bristol-Myers Squibb (BMY) have jointly discovered a novel antiobesity drug candidate that targets the thyroid hormone receptor. BMS has now filed an Investigational New Drug (IND)...

Tranzyme Collaborates To Apply TExT Gene Expression.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Tranzyme Inc. and NeoGenesis Drug Discovery Inc., have entered into a collaboration in the areas of gene expression and protein function discovery. This alliance will utilize Tranzyme's recently...

NeoTherapeutics Appoints Assistant Medical Director.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- NeoTherapeutics Inc. (NEOT, NEOTW) has hired Dr. Rosemarie Rosales as Assistant Director, Medical Research of its oncology subsidiary NeoOncoRx. Dr. Rosales will assist in clinical study design,...

NeoTherapeutics Eliminates All Convertible And Reset Financings.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Societe Generale has fully converted and redeemed its $2 million NeoTherapeutics Inc. (NEOT) preferred stock investment. Societe Generale acquired these shares through the exchange of $2 million of...

Soybean Derivative Touchi Improves Fasting Glucose, Glycemic Control.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A controlled study of the soybean derivative Touchi has shown it may improve glycemic control in adults with borderline or mild cases of type 2 diabetes....

Bayer Diagnostics Announces Expanded Agreement On Blood-Gas Systems.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- Bayer Corp. has signed an agreement for its Diagnostics Division with Premier Inc. to provide Premier's members with its full line of blood gas products. Premier is among the largest not-for-profit...

Scientist Recognized For High-Throughput Screening Innovation.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- For outstanding contribution and innovation in the drug discovery area, The Society for Biomolecular Screening (SBS) has awarded Promega Corp. scientist Keith Wood the PerkinElmer Life Sciences...

FDA Funds Development Of GMO Detection System.
October 10, 2001... 2001 OCT 10 - (NewsRx.com & NewsRx.net) -- The Food and Drug Administration has awarded a Phase I Small Business Innovation Research (SBIR) grant worth $100,000 to Third Wave Agbio Inc. to fund research about high-throughput, low-cost...

Novel HGP-30 Conjugates Enhance Immunogenicity.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States say that they have improved the performance of a potential HIV vaccine. "HGP-30, a 30 amino acid synthetic peptide...

Adefovir Has Limited Effect On Drug Resistance Risk.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The nucleotide analog adefovir dipivoxil (ADV) can affect the frequency of HIV reverse transcriptase mutations conferring increased drug resistance although...

Liposomal Vaccine Show Specific Immunotherapy In Stage III Disease.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Biomira, Inc. reports that its liposomal candidate vaccine has shown specific immunotherapy in a Phase I study of non-small cell lung cancer. The trial involved 16 evaluable patients with non-small...

Recombinant Bordetella Boosts Neisseria Vaccine Development.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A better way of preparing vaccines against Neisseria meningitidis may soon be on the horizon if studies now being performed in France continue to show positive...

Bone Mineral Density Exam As An Indicator Of Fracture Risk Simplified.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- CompuMed, Inc. presented findings of an investigation of phalangeal bone mineral density (BMD) in a normal Chinese population at the First International Conference on Bone Mineral Research, held in...

Phase III Data Suggests Antibiotic Is Better Than Standard Therapy.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc. released clinical results September 24, 2001, expanding on data published in the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) abstracts....

Sequencing Of Pyrolobus fumarii Genome Completed.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Diversa Corporation announced September 25, 2001, the completion of the sequencing of the Pyrolobus fumarii genome. P. fumarii was discovered in the wall of a black smoker, or a deep-sea...

Intravenous Ig Therapy Can Help Some Patients.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Patients suffering from reactive macrophage activation episodes can benefit from prompt intravenous immunoglobulin administration, researchers in Switzerland...

AGY Therapeutics Names Roman Urfer Vice President Of Drug Discovery And Development.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Roman Urfer, PhD, has been appointed vice president of drug discovery and development AGY Therapeutics, a privately held biotechnology company. Dr. Urfer joins AGY from Novartis Pharma AG of Basel,...

Long-Term Release Hormone Therapy Product Is Promising.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc. announced September 20, 2001, the presentation of Phase III clinical results for the company's Leuprogel Three-Month Depot prostate cancer treatment at the Eighth Annual CaP...

Bayer Plans to Form Separate Companies For Health Care And Crop Protection.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Bayer AG plans to transfer its current health care business segment into an independent corporate unit within the Bayer Group and to acquire the crop protection activities of Aventis CropScience, also...

Aventis Pasteur To Complete Flu Vaccine Shipments By November.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Aventis Pasteur, the nation's leading supplier of influenza vaccine, says it anticipates shipping all influenza vaccine orders to customers by the end of November (2001). Smaller customers were...

Bayer Submits New Drug Application For Vardenafil.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Bayer Corporation has submitted a New Drug Application (NDA) for vardenafil, an investigational compound for the improvement of erectile function, to the U.S. Food and Drug Administration (FDA)....

Computational Drug Discovery Raises $7.8 Million.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Bio IT, a computational drug discovery company focused on membrane-embedded proteins, has completed its first round of financing, totaling US$7.8 million from OrbiMed Advisors LLC, Yozma, and Lehman...

Embolic Protection Device Gets CE Mark For Carotid Application.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- The FilterWire EX embolic protection device has received the CE Mark for the carotid application, reported Boston Scientific Corp. (BSX). The device received the CE mark for coronary and saphenous...

Advisory Board To Guide Development of E2f Decoy in Cardiovascular Diseases.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- The privately held biotechnology company Corgentech Inc. has established a seven-member clinical advisory board comprising surgical experts in the fields of heart and vascular disease. The advisory...

AuraZyme Presents Progress Report On Cancer Drug Delivery System.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- AuraZyme Pharmaceuticals Inc., a subsidiary of CryoLife Inc. (CRY), presented results of animal studies on its A-Z-CINN Linker for targeted delivery of anticancer chemotherapy drugs, at the recent...

Dendreon Acquires Rights To Key Cancer Antigens From Bayer.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Dendreon Corp. (DNDN) today announced it has entered into agreements with Bayer, Tarrytown, New York, to license two prominent tumor antigens for use in Dendreon's therapeutic cancer vaccines. The...

Enchira Announces Stock Buyback.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Enchira Biotechnology Corp. (ENBC) has repurchased 1,080,000 shares of common stock from several stockholders whose shares were managed by OrbiMed Advisors LLC and its affiliates. The stock was sold...

Eos Names Dale Johnson Vice President, Preclinical And Predictive Development.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Dale E. Johnson, PharmD, PhD, has joined Eos Biotechnology Inc. as vice president, preclinical and predictive development. In this position he will be responsible for the preclinical development of...

Two Patents Issued For Antifungal Drug Discovery Program.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- The United States Patent and Trademark Office has issued two patents covering geranylgeranyl transferase type 1 (GGTase) as an antifungal drug target. The GGTase program is GPC Biotech AG's most...

Genencor Meets First Technical Milestone in Biomass-to-Ethanol Project.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- Genencor International Inc. has achieved its first technical milestone in its three-year contract with the U.S. Department of Energy (DOE) Biofuels Program administered by DOE's National Renewable...

Introgen Gets Worldwide License For Anticancer Therapy.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- The U.S. Patent and Trademark Office has issued to the Board of Regents of The University of Texas System a patent covering the administration of chemotherapeutic drugs, radiation therapies, or other...

Sulodexide Gets Fast Track Status.
October 17, 2001... 2001 OCT 17 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has designated KRX-101 (sulodexide), developed by Keryx Biopharmaceuticals (KERX, KRX) for the treatment of diabetic nephropathy, as a fast track product....